Arista Biologicals
rHIV gp36
Catalog #AGHIV-0219
ApplicationLFA
AGHIV-0219
Bulk quantities and custom vialing available.
Product Description
HIV-2 gp36 envelope glycoprotein, produced via E. coli recombinant expression and ion-exchange purified, serves as a validated antigenic target for HIV-2 antibody detection. Provides consistent and stable performance for LFA assay development. Suitable as a capture reagent.
Specifications
Conjugate Type
Unconjugated
Purity
Ion-exchange Chromatography Purified
Product Information
Application
LFA
Buffer
20 mM Carbonate Buffer with 0.1% Sodium Azide, pH 9.5
Storage
2 - 8 °C
Physical State
Liquid
Shelf Life
1 year from date of receipt
Country of Origin
USA
Applications
Not for human, therapeutic, or in-vivo use. For research and further manufacturer use only.
Related Products
Services
Need a different format?
Custom purification, concentration or buffer formulation, built to your specifications.
Request Customization
Need LFA development support?
Process development, manufacturing from feasibility through commercial production
Request Customization
Need a custom gold nanoparticle?
Need custom Gold nanoparticles? Various sizes, shapes, surface modifications, and custom options.
Request Customization
Resources
Control Line Systems for Lateral Flow Assays
Read the Article
Lateral Flow Assay Development Guide
Read the Guide
Enhancing Sensitivity in Lateral Flow Assays Using Passively Conjugated Gold Nanoshells
Read the Article
Flexible product configurations, and scalable supply.
Purpose-designated for capture, detection, or both in rapid-test development.
Bulk quantities, custom formulations and gold conjugation option are available to support your projects needs.